Such findings suggest that GSTM3 may act as a protective factor in bladder cancer, and our MR results are consistent with this - indicating that higher GSTM3 expression is associated with lower bladder cancer risk (a protective effect). Here, GSTM3 is linked to urinary bladder carcinoma.